Copyright
©The Author(s) 2024.
World J Gastroenterol. Jun 7, 2024; 30(21): 2793-2816
Published online Jun 7, 2024. doi: 10.3748/wjg.v30.i21.2793
Published online Jun 7, 2024. doi: 10.3748/wjg.v30.i21.2793
Figure 7 Effects of Thymoquinone on PI3K/AKT/mTOR upstream pathway of hypoxia-inducible factor-1αprotein under hypoxia condition.
A: Western blot assay was performed to detect the expression of p-PI3K-p85α, p-AKT, p-mTOR, p-S6K, p-4E-BP1 and eIF-4E of PANC-1 cells in normal control (NC) group and Thymoquinone (TQ) group under hypoxia condition; B: Statistical analysis of the expression of p-PI3K-p85α, p-AKT, p-mTOR, p-S6K, p-4E-BP1 and eIF-4E of PANC-1 cells in NC and TQ groups under hypoxia condition. aP < 0.05; bP < 0.01. NC: Normal control; TQ: Thymoquinone.
- Citation: Zhao ZX, Li S, Liu LX. Thymoquinone affects hypoxia-inducible factor-1α expression in pancreatic cancer cells via HSP90 and PI3K/AKT/mTOR pathways. World J Gastroenterol 2024; 30(21): 2793-2816
- URL: https://www.wjgnet.com/1007-9327/full/v30/i21/2793.htm
- DOI: https://dx.doi.org/10.3748/wjg.v30.i21.2793